BioCentury
ARTICLE | Company News

ActiveSight sales and marketing update

July 12, 2004 7:00 AM UTC

The company launched an Hsp90 co-crystallization service, under which it will solve the crystal structures of compounds bound in the active site of the cancer target Hsp90. ...